4th Quarter - Amendment — EPILEPSY FOUNDATION for EPILEPSY FOUNDATION (2017)

Firm

EPILEPSY FOUNDATION

Client

EPILEPSY FOUNDATION

Income

—

Expenses

$60,000

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Report	Nov 30, 2017	$60,000	Replaced
4th Quarter - Amendment (this page)	Mar 13, 2018	$60,000	Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

NIH, CDC, FDA and health care/public health appropriations

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
ANGELA OSTROM	—

Contacted: White House Office; Equal Employment Opportunity Commission (EEOC); Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Justice, Dept of (DOJ); SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Civil Rights/Civil Liberties CIV

ADA, employment discrimination, access to education, ending stigma surrounding epilepsy, disability rights

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
ANGELA OSTROM	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); White House Office; SENATE; Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Equal Employment Opportunity Commission (EEOC)

Health Issues HCR

Health care reform, Medicare, Medicaid, access to care

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
ANGELA OSTROM	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS); Equal Employment Opportunity Commission (EEOC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Centers For Disease Control & Prevention (CDC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.